Payer AI Spend 2026: Capital Flows to Denial Appeals

Frequently Asked Questions

01.How much capital is flowing into payer AI in 2026?

Global AI spend is projected to reach 2.59 trillion dollars in 2026, up 47 percent year over year, according to Gartner data reported by CIO Dive. Denial appeal and revenue cycle automation account for a growing share of that spend as payers and providers chase the 43 billion dollars hospitals spent in 2025 fighting denials and prior authorizations.

02.Why do denial appeals attract more capital than other payer AI use cases?

Denial appeals have measurable, auditable financial returns. Vendors report preventing billions of dollars in denials and cutting appeal turnaround from days to minutes, which gives allocators a clean ROI signal that other payer AI categories, such as member engagement chat, cannot yet demonstrate.

03.What should a capital allocator underwrite before funding a denial-appeals AI platform?

Underwrite the auditability of the appeal-generation pipeline, its accuracy against payer-specific policy manuals, its integration surface with existing claims and EHR systems, and its compliance posture against CMS interoperability and state prompt-payment rules. Weak audit trails are the most common reason pilots stall before scale.